Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom-Reply. [electronic resource]
- JAMA oncology 03 2019
- 428-429 p. digital
Publication Type: Journal Article; Comment
2374-2445
10.1001/jamaoncol.2018.6504 doi
Breast Neoplasms Cost-Benefit Analysis Early Detection of Cancer Humans Mammography Mass Screening United Kingdom